Phase II, Randomized, Placebo-Controlled, Double-Blind Study of Minocycline in the Treatment of HIV-Associated Cognitive Impairment.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Minocycline (Primary)
- Indications Mild cognitive impairment
- Focus Biomarker; Therapeutic Use
- 05 Feb 2016 Biomarkers information updated
- 06 Mar 2013 Results on oxidative stress and neuronal injury markers presented at the 20th Conference on Retroviruses and Opportunistic Infections.
- 07 Sep 2011 Results published in the Neurology.